BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18538745)

  • 1. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications.
    Wójcikowski J; Gołembiowska K; Daniel WA
    Biochem Pharmacol; 2008 Jul; 76(2):258-67. PubMed ID: 18538745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat.
    Wójcikowski J; Daniel WA
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):631-45. PubMed ID: 19442036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression.
    Sadakierska-Chudy A; Haduch A; Rysz M; Gołembiowska K; Daniel WA
    Biochem Pharmacol; 2013 Sep; 86(6):800-7. PubMed ID: 23924605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of factors mediating the effect of the brain dopaminergic system on the expression of cytochrome P450 in the liver.
    Wójcikowski J; Daniel WA
    Pharmacol Rep; 2008; 60(6):966-71. PubMed ID: 19211990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
    Bromek E; Wójcikowski J; Daniel WA
    Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of liver cytochrome p450 by the brain dopaminergic system.
    Wójcikowski J; Gołembiowska K; Daniel WA
    Curr Drug Metab; 2007 Aug; 8(6):631-8. PubMed ID: 17691922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the nervous system in the regulation of liver cytochrome p450.
    Wójcikowski J; Daniel WA
    Curr Drug Metab; 2011 Feb; 12(2):124-38. PubMed ID: 21401511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
    Mukda S; Kaewsuk S; Ebadi M; Govitrapong P
    Dev Neurosci; 2009; 31(3):193-201. PubMed ID: 19145071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
    Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
    Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity.
    Kot M; Sadakierska-Chudy A; Haduch A; Rysz M; Bromek E; Gołembiowska K; Daniel WA
    Eur J Pharmacol; 2015 Mar; 751():34-41. PubMed ID: 25637782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450.
    Rysz M; Bromek E; Haduch A; Sadakierska-Chudy A; Daniel WA
    Drug Metab Dispos; 2015 Sep; 43(9):1345-52. PubMed ID: 26059263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of brain serotonergic system by repeated intracerebral administration of 5-hydroxytryptophan (5-HTP) decreases the expression and activity of liver cytochrome P450.
    Rysz M; Bromek E; Daniel WA
    Biochem Pharmacol; 2016 Jan; 99():113-22. PubMed ID: 26581122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes.
    Borbás T; Benko B; Dalmadi B; Szabó I; Tihanyi K
    Eur J Pharm Sci; 2006 May; 28(1-2):51-8. PubMed ID: 16488120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-receptor-linked signaling pathways regulate the expression of hepatic CYP2E1.
    Konstandi M; Harkitis P; Kostakis D; Marselos M; Johnson EO; Lang MA
    Life Sci; 2008 Jan; 82(1-2):1-10. PubMed ID: 17988693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats.
    Morales-Medina JC; Mejorada A; Romero-Curiel A; Aguilar-Alonso P; León-Chávez BA; Gamboa C; Quirion R; Flores G
    Neuropharmacology; 2008 Dec; 55(8):1313-20. PubMed ID: 18790702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet.
    Kot M; Pilc A; Daniel WA
    Pharmacol Res; 2012 Oct; 66(4):292-9. PubMed ID: 22749902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of the brain dopaminergic system in the regulation of cytochrome P-450 expression.
    Wójcikowski J
    Pol J Pharmacol; 2004; 56(6):701-8. PubMed ID: 15662082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 is regulated by noradrenergic and serotonergic systems.
    Kot M; Daniel WA
    Pharmacol Res; 2011 Oct; 64(4):371-80. PubMed ID: 21742037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D₂-dopaminergic receptor-linked pathways: critical regulators of CYP3A, CYP2C, and CYP2D.
    Daskalopoulos EP; Lang MA; Marselos M; Malliou F; Konstandi M
    Mol Pharmacol; 2012 Oct; 82(4):668-78. PubMed ID: 22772593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of dopamine D2 receptors in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats.
    Abe K; Niikura Y; Fujimoto T; Akaishi T; Misawa M
    Neuropharmacology; 2008 Dec; 55(8):1419-24. PubMed ID: 18835399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.